אלוריל 300

Country: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

ALLOPURINOL

Boleh didapati daripada:

DEXCEL LTD, ISRAEL

Kod ATC:

M04AA01

Borang farmaseutikal:

טבליה

Komposisi:

ALLOPURINOL 300 MG

Laluan pentadbiran:

פומי

Jenis preskripsi:

מרשם נדרש

Dikeluarkan oleh:

DEXCEL LTD, ISRAEL

Kumpulan terapeutik:

ALLOPURINOL

Kawasan terapeutik:

ALLOPURINOL

Tanda-tanda terapeutik:

Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.

Tarikh kebenaran:

2014-02-28